カテゴリー： QYResearch, 世界, 医療/バイオ

世界の分子診断感染症検査市場インサイト及び予測（細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査）

◆英語タイトル：Global Molecular Diagnostics Infectious Disease Testing Market Insights, Forecast to 2028
	◆商品コード：QY22JLX09254 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：114 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、分子診断感染症検査のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に分子診断感染症検査の世界市場のxxx％を占める「細菌感染症検査」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
分子診断感染症検査の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの分子診断感染症検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

分子診断感染症検査のグローバル主要企業には、Abbott Laboratories、BD、bioMérieux、Thermo Fisher Scientific、F. Hoffmann-La Roche、Siemens AG、Veridex、Luminex、GenMark Diagnostics、Qiagen NV、Genomix Biotech、BioTheranostics、GenMark Diagnosticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

分子診断感染症検査市場は、種類と用途によって区分されます。世界の分子診断感染症検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査

【用途別セグメント】
病院、実験室研究

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 分子診断感染症検査製品概要
- 種類別市場（細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査）
- 用途別市場（病院、実験室研究）
- 調査の目的
・エグゼクティブサマリー
- 世界の分子診断感染症検査販売量予測2017-2028
- 世界の分子診断感染症検査売上予測2017-2028
- 分子診断感染症検査の地域別販売量
- 分子診断感染症検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別分子診断感染症検査販売量
- 主要メーカー別分子診断感染症検査売上
- 主要メーカー別分子診断感染症検査価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査）
- 分子診断感染症検査の種類別販売量
- 分子診断感染症検査の種類別売上
- 分子診断感染症検査の種類別価格
・用途別市場規模（病院、実験室研究）
- 分子診断感染症検査の用途別販売量
- 分子診断感染症検査の用途別売上
- 分子診断感染症検査の用途別価格
・北米市場
- 北米の分子診断感染症検査市場規模（種類別、用途別）
- 主要国別の分子診断感染症検査市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの分子診断感染症検査市場規模（種類別、用途別）
- 主要国別の分子診断感染症検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の分子診断感染症検査市場規模（種類別、用途別）
- 主要国別の分子診断感染症検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の分子診断感染症検査市場規模（種類別、用途別）
- 主要国別の分子診断感染症検査市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの分子診断感染症検査市場規模（種類別、用途別）
- 主要国別の分子診断感染症検査市場規模（トルコ、サウジアラビア）
・企業情報
Abbott Laboratories、BD、bioMérieux、Thermo Fisher Scientific、F. Hoffmann-La Roche、Siemens AG、Veridex、Luminex、GenMark Diagnostics、Qiagen NV、Genomix Biotech、BioTheranostics、GenMark Diagnostics
・産業チェーン及び販売チャネル分析
- 分子診断感染症検査の産業チェーン分析
- 分子診断感染症検査の原材料
- 分子診断感染症検査の生産プロセス
- 分子診断感染症検査の販売及びマーケティング
- 分子診断感染症検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 分子診断感染症検査の産業動向
- 分子診断感染症検査のマーケットドライバー
- 分子診断感染症検査の課題
- 分子診断感染症検査の阻害要因
・主な調査結果

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others.
Market Analysis and Insights: Global Molecular Diagnostics Infectious Disease Testing Market
The global Molecular Diagnostics Infectious Disease Testing market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Bacterial Infectious Disease Testing accounting for % of the Molecular Diagnostics Infectious Disease Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Molecular Diagnostics Infectious Disease Testing market size is valued at US$ million in 2021, while the North America and Europe Molecular Diagnostics Infectious Disease Testing are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Molecular Diagnostics Infectious Disease Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics Infectious Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics Infectious Disease Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics Infectious Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics Infectious Disease Testing market.
Global Molecular Diagnostics Infectious Disease Testing Scope and Market Size
Molecular Diagnostics Infectious Disease Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics Infectious Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Bacterial Infectious Disease Testing
Viral Infectious Disease Testing
Parasitic Infectious Disease Testing
Segment by Application
Hospital
Laboratory Research
By Company
Abbott Laboratories
BD
bioMérieux
Thermo Fisher Scientific
F. Hoffmann-La Roche
Siemens AG
Veridex
Luminex
GenMark Diagnostics
Qiagen NV
Genomix Biotech
BioTheranostics
GenMark Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Bacterial Infectious Disease Testing
1.2.3 Viral Infectious Disease Testing
1.2.4 Parasitic Infectious Disease Testing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Infectious Disease Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Infectious Disease Testing Market Perspective (2017-2028)
2.2 Molecular Diagnostics Infectious Disease Testing Growth Trends by Region
2.2.1 Molecular Diagnostics Infectious Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Molecular Diagnostics Infectious Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Molecular Diagnostics Infectious Disease Testing Market Dynamics
2.3.1 Molecular Diagnostics Infectious Disease Testing Industry Trends
2.3.2 Molecular Diagnostics Infectious Disease Testing Market Drivers
2.3.3 Molecular Diagnostics Infectious Disease Testing Market Challenges
2.3.4 Molecular Diagnostics Infectious Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue
3.1.1 Global Top Molecular Diagnostics Infectious Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Molecular Diagnostics Infectious Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Molecular Diagnostics Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Infectious Disease Testing Revenue
3.4 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Infectious Disease Testing Revenue in 2021
3.5 Molecular Diagnostics Infectious Disease Testing Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Infectious Disease Testing Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Infectious Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Type
4.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics Infectious Disease Testing Breakdown Data by Application
5.1 Global Molecular Diagnostics Infectious Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Molecular Diagnostics Infectious Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
6.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Type
6.2.1 North America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
6.2.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
6.2.3 North America Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
6.3 North America Molecular Diagnostics Infectious Disease Testing Market Size by Application
6.3.1 North America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
6.3.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
6.3.3 North America Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
6.4 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country
6.4.1 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
6.4.2 North America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
7.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type
7.2.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
7.2.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
7.2.3 Europe Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
7.3 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application
7.3.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
7.3.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
7.3.3 Europe Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
7.4 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country
7.4.1 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
7.4.2 Europe Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Molecular Diagnostics Infectious Disease Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
9.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Type
9.2.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
9.2.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
9.2.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
9.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Application
9.3.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
9.3.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
9.3.3 Latin America Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
9.4 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country
9.4.1 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
9.4.2 Latin America Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Molecular Diagnostics Infectious Disease Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Molecular Diagnostics Infectious Disease Testing Introduction
11.1.4 Abbott Laboratories Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Molecular Diagnostics Infectious Disease Testing Introduction
11.2.4 BD Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.2.5 BD Recent Developments
11.3 bioMérieux
11.3.1 bioMérieux Company Details
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Molecular Diagnostics Infectious Disease Testing Introduction
11.3.4 bioMérieux Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.3.5 bioMérieux Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Molecular Diagnostics Infectious Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Molecular Diagnostics Infectious Disease Testing Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Siemens AG
11.6.1 Siemens AG Company Details
11.6.2 Siemens AG Business Overview
11.6.3 Siemens AG Molecular Diagnostics Infectious Disease Testing Introduction
11.6.4 Siemens AG Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.6.5 Siemens AG Recent Developments
11.7 Veridex
11.7.1 Veridex Company Details
11.7.2 Veridex Business Overview
11.7.3 Veridex Molecular Diagnostics Infectious Disease Testing Introduction
11.7.4 Veridex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.7.5 Veridex Recent Developments
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Molecular Diagnostics Infectious Disease Testing Introduction
11.8.4 Luminex Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.8.5 Luminex Recent Developments
11.9 GenMark Diagnostics
11.9.1 GenMark Diagnostics Company Details
11.9.2 GenMark Diagnostics Business Overview
11.9.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.9.5 GenMark Diagnostics Recent Developments
11.10 Qiagen NV
11.10.1 Qiagen NV Company Details
11.10.2 Qiagen NV Business Overview
11.10.3 Qiagen NV Molecular Diagnostics Infectious Disease Testing Introduction
11.10.4 Qiagen NV Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.10.5 Qiagen NV Recent Developments
11.11 Genomix Biotech
11.11.1 Genomix Biotech Company Details
11.11.2 Genomix Biotech Business Overview
11.11.3 Genomix Biotech Molecular Diagnostics Infectious Disease Testing Introduction
11.11.4 Genomix Biotech Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.11.5 Genomix Biotech Recent Developments
11.12 BioTheranostics
11.12.1 BioTheranostics Company Details
11.12.2 BioTheranostics Business Overview
11.12.3 BioTheranostics Molecular Diagnostics Infectious Disease Testing Introduction
11.12.4 BioTheranostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.12.5 BioTheranostics Recent Developments
11.13 GenMark Diagnostics
11.13.1 GenMark Diagnostics Company Details
11.13.2 GenMark Diagnostics Business Overview
11.13.3 GenMark Diagnostics Molecular Diagnostics Infectious Disease Testing Introduction
11.13.4 GenMark Diagnostics Revenue in Molecular Diagnostics Infectious Disease Testing Business (2017-2022)
11.13.5 GenMark Diagnostics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の分子診断感染症検査市場インサイト及び予測（細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査）(Global Molecular Diagnostics Infectious Disease Testing Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の分子診断感染症検査市場インサイト及び予測（細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp